Advertisements
Huitema, Alwin D.R.

Huitema, Alwin D.R.

Princess Máxima Center for Pediatric Oncology, Netherlands

2025 Rank: 209,985

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Pharmacology & Pharmacy

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 1,622 out of 157,499 Researchers

Data For The Year: 2025
Metrics Self-Citations Excluded All
Rank Based on Composite Score209,985204,090
Total Cites1,3561,620
H-index1517
Hm-index67
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers2323
Total Cites to Single+First Authored Papers55
Number of Single+First+Last Authored Papers188188
Total Cites to Single+First+Last Authored Papers308355
Composite Score22
Number of Distinct Citing Papers1,1051,220
Ratio of Total Citations to Distinct Citing Papers 1.23 1.33
Self-Citation Percentage
16.30%
Found an error in your data? Contact us with your profile link. Contact Us →
Huitema, Alwin D.R.

Huitema, Alwin D.R.

The Netherlands Cancer Institute, Netherlands

2024 Rank: 167,968

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Pharmacology & Pharmacy

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 1,218 out of 148,458 Researchers

Data For The Year: 2024
Metrics Self-Citations Excluded All
Rank Based on Composite Score167,968173,418
Total Cites1,2971,511
H-index1516
Hm-index66
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers2323
Total Cites to Single+First Authored Papers89
Number of Single+First+Last Authored Papers179179
Total Cites to Single+First+Last Authored Papers322371
Composite Score22
Number of Distinct Citing Papers1,0501,133
Ratio of Total Citations to Distinct Citing Papers 1.24 1.33
Self-Citation Percentage
14.16%
Found an error in your data? Contact us with your profile link. Contact Us →
Huitema, Alwin D.R.

Huitema, Alwin D.R.

The Netherlands Cancer Institute, Netherlands

2023 Rank: 202,676

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Pharmacology & Pharmacy

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 1,555 out of 140,593 Researchers

Data For The Year: 2023
Metrics Self-Citations Excluded All
Rank Based on Composite Score202,676197,069
Total Cites1,1591,359
H-index1314
Hm-index56
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers2323
Total Cites to Single+First Authored Papers910
Number of Single+First+Last Authored Papers171171
Total Cites to Single+First+Last Authored Papers312358
Composite Score22
Number of Distinct Citing Papers9451,043
Ratio of Total Citations to Distinct Citing Papers 1.23 1.30
Self-Citation Percentage
14.72%
Found an error in your data? Contact us with your profile link. Contact Us →
Huitema, Alwin D.R.

Huitema, Alwin D.R.

The Netherlands Cancer Institute, Netherlands

2020 Rank: 198,188

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Pharmacology & Pharmacy

SubField 2:

Oncology & Carcinogenesis

Rank in SubField 1: 1,405 out of 94,611 Researchers

Data For The Year: 2020
Metrics Self-Citations Excluded All
Rank Based on Composite Score198,188190,855
Total Cites9811,175
H-index1213
Hm-index56
Number of Single Authored Papers11
Total Cites to Single Authored Papers00
Number of Single+First Authored Papers2323
Total Cites to Single+First Authored Papers1415
Number of Single+First+Last Authored Papers140140
Total Cites to Single+First+Last Authored Papers321382
Composite Score22
Number of Distinct Citing Papers808880
Ratio of Total Citations to Distinct Citing Papers 1.21 1.34
Self-Citation Percentage
16.51%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements